skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 13,115  for All Library Resources

Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The Effect of Manager Forecast of Future Sales on Company Risk During Sales Decline Using the Fama-French Five-Factor Model
Material Type:
Article
Add to My Research

The Effect of Manager Forecast of Future Sales on Company Risk During Sales Decline Using the Fama-French Five-Factor Model

Iranian journal of management studies, 2021-06, Vol.14 (3), p.509-525 [Peer Reviewed Journal]

COPYRIGHT 2021 University of Tehran, Farabi College ;2021. This work is published under https://creativecommons.org/licenses/by/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2008-7055 ;EISSN: 2345-3745 ;DOI: 10.22059/IJMS.2021.296411.673936

Full text available

2
Teva Pharmaceutical Industries (TEVA: NIS38.90) loses NIS689 million ($180 million) (1.6%) in MCap, steepest heavyweight fall in TA-25 Index
Material Type:
Newsletter Article
Add to My Research

Teva Pharmaceutical Industries (TEVA: NIS38.90) loses NIS689 million ($180 million) (1.6%) in MCap, steepest heavyweight fall in TA-25 Index

Company Data Report, 2023

Copyright News Bites Pty Ltd Sep 27, 2023

Digital Resources/Online E-Resources

3
Teva Pharmaceutical Industries (TEVA: NIS39.52) loses NIS866 million ($227 million) (1.9%) in MCap, steepest heavyweight fall in Pharmaceuticals Medical Research Sector
Material Type:
Newsletter Article
Add to My Research

Teva Pharmaceutical Industries (TEVA: NIS39.52) loses NIS866 million ($227 million) (1.9%) in MCap, steepest heavyweight fall in Pharmaceuticals Medical Research Sector

Company Data Report, 2023

Copyright News Bites Pty Ltd Sep 26, 2023

Digital Resources/Online E-Resources

4
Teva Pharmaceutical Industries (TEVA: NIS40.30) strengthens above moving average price
Material Type:
Newsletter Article
Add to My Research

Teva Pharmaceutical Industries (TEVA: NIS40.30) strengthens above moving average price

Company Data Report, 2023

Copyright News Bites Pty Ltd Sep 20, 2023

Digital Resources/Online E-Resources

5
Teva Pharmaceutical Industries (TEVA: NIS40.59) hits year-high 3rd time in three months
Material Type:
Newsletter Article
Add to My Research

Teva Pharmaceutical Industries (TEVA: NIS40.59) hits year-high 3rd time in three months

Company Data Report, 2023

Copyright News Bites Pty Ltd Sep 18, 2023

Digital Resources/Online E-Resources

6
Teva Pharmaceutical Industries (TEVA: NIS40.30) in top 1% performers of TA-25 Index, hits thirty-two-month high
Material Type:
Newsletter Article
Add to My Research

Teva Pharmaceutical Industries (TEVA: NIS40.30) in top 1% performers of TA-25 Index, hits thirty-two-month high

Company Data Report, 2023

Copyright News Bites Pty Ltd Sep 14, 2023

Digital Resources/Online E-Resources

7
Teva Pharmaceutical Industries (TEVA: NIS36.81) increases 0.5% against the trend
Material Type:
Newsletter Article
Add to My Research

Teva Pharmaceutical Industries (TEVA: NIS36.81) increases 0.5% against the trend

Company Data Report, 2023

Copyright News Bites Pty Ltd Sep 4, 2023

Digital Resources/Online E-Resources

8
Teva Pharmaceutical Industries (TEVA: NIS36.62) loses NIS422 million ($111 million) (1.0%) in MCap, steepest heavyweight fall in TA-25 Index
Material Type:
Newsletter Article
Add to My Research

Teva Pharmaceutical Industries (TEVA: NIS36.62) loses NIS422 million ($111 million) (1.0%) in MCap, steepest heavyweight fall in TA-25 Index

Company Data Report, 2023

Copyright News Bites Pty Ltd Sep 3, 2023

Digital Resources/Online E-Resources

9
Teva Pharmaceutical Industries (TEVA: NIS37.0) adds NIS489 million ($129 million) (1.2%) in MCap, top heavyweight rise in Pharmaceuticals Medical Research Sector
Material Type:
Newsletter Article
Add to My Research

Teva Pharmaceutical Industries (TEVA: NIS37.0) adds NIS489 million ($129 million) (1.2%) in MCap, top heavyweight rise in Pharmaceuticals Medical Research Sector

Company Data Report, 2023

Copyright News Bites Pty Ltd Aug 31, 2023

Digital Resources/Online E-Resources

10
Teva Pharmaceutical Industries (TEVA: NIS37.37) rises in 4 out of last 5 days; 5-day rise of 4.4
Material Type:
Newsletter Article
Add to My Research

Teva Pharmaceutical Industries (TEVA: NIS37.37) rises in 4 out of last 5 days; 5-day rise of 4.4

Company Data Report, 2023

Copyright News Bites Pty Ltd Aug 24, 2023

Digital Resources/Online E-Resources

11
Teva Pharmaceutical Industries (TEVA: NIS40.30) outperforming 98% of stocks, reports 5.9% sequential rise in Quarterly Revenue
Material Type:
Newsletter Article
Add to My Research

Teva Pharmaceutical Industries (TEVA: NIS40.30) outperforming 98% of stocks, reports 5.9% sequential rise in Quarterly Revenue

Company Data Report, 2023

Copyright News Bites Pty Ltd Sep 21, 2023

Digital Resources/Online E-Resources

12
Checkpoint Therapeutics (CKPT: $1.97) drops 1.5%; -3c [-1.5%]
Material Type:
Newsletter Article
Add to My Research

Checkpoint Therapeutics (CKPT: $1.97) drops 1.5%; -3c [-1.5%]

News Bites US - NASDAQ, 2023

Copyright News Bites Pty Ltd Sep 12, 2023

Digital Resources/Online E-Resources

13
Checkpoint Therapeutics (CKPT: $2.0) climbs 2.6%; +5c [2.6%]
Material Type:
Newsletter Article
Add to My Research

Checkpoint Therapeutics (CKPT: $2.0) climbs 2.6%; +5c [2.6%]

News Bites US - NASDAQ, 2023

Copyright News Bites Pty Ltd Sep 11, 2023

Digital Resources/Online E-Resources

14
Teva Pharmaceutical Industries (TEVA: NIS36.18) drops 1.3%, 4 days' volume in a day
Material Type:
Newsletter Article
Add to My Research

Teva Pharmaceutical Industries (TEVA: NIS36.18) drops 1.3%, 4 days' volume in a day

Company Data Report, 2023

Copyright News Bites Pty Ltd Sep 6, 2023

Digital Resources/Online E-Resources

15
Teva Pharmaceutical Industries (TEVA: NIS36.65) decreases on spectacular volume
Material Type:
Newsletter Article
Add to My Research

Teva Pharmaceutical Industries (TEVA: NIS36.65) decreases on spectacular volume

Company Data Report, 2023

Copyright News Bites Pty Ltd Sep 5, 2023

Digital Resources/Online E-Resources

16
Teva Pharmaceutical Industries (TEVA: NIS36.10) loses NIS1 billion ($371 million) (3.4%) in MCap, steepest heavyweight fall in TA-25 Index
Material Type:
Newsletter Article
Add to My Research

Teva Pharmaceutical Industries (TEVA: NIS36.10) loses NIS1 billion ($371 million) (3.4%) in MCap, steepest heavyweight fall in TA-25 Index

Company Data Report, 2023

Copyright News Bites Pty Ltd Aug 27, 2023

Digital Resources/Online E-Resources

17
Teva Pharmaceutical Industries (TEVA: NIS37.03) loses NIS566 million ($150 million) (1.4%) in MCap, steepest heavyweight fall in Pharmaceuticals Medical Research Sector
Material Type:
Newsletter Article
Add to My Research

Teva Pharmaceutical Industries (TEVA: NIS37.03) loses NIS566 million ($150 million) (1.4%) in MCap, steepest heavyweight fall in Pharmaceuticals Medical Research Sector

Company Data Report, 2023

Copyright News Bites Pty Ltd Aug 23, 2023

Digital Resources/Online E-Resources

18
Teva Pharmaceutical Industries (TEVA: NIS35.77) hits five-month high on strong volume
Material Type:
Newsletter Article
Add to My Research

Teva Pharmaceutical Industries (TEVA: NIS35.77) hits five-month high on strong volume

Company Data Report, 2023

Copyright News Bites Pty Ltd Aug 7, 2023

Digital Resources/Online E-Resources

19
Teva Pharmaceutical Industries (TEVA: NIS34.28) falls 0.8% from 14-day high
Material Type:
Newsletter Article
Add to My Research

Teva Pharmaceutical Industries (TEVA: NIS34.28) falls 0.8% from 14-day high

Company Data Report, 2023

Copyright News Bites Pty Ltd Aug 3, 2023

Digital Resources/Online E-Resources

20
Teva Pharmaceutical Industries (TEVA: NIS34.57) in top 1% performers of TA-25 Index, hits 111-day high
Material Type:
Newsletter Article
Add to My Research

Teva Pharmaceutical Industries (TEVA: NIS34.57) in top 1% performers of TA-25 Index, hits 111-day high

Company Data Report, 2023

Copyright News Bites Pty Ltd Aug 2, 2023

Digital Resources/Online E-Resources

Results 1 - 20 of 13,115  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2008  (8)
  2. 2008 To 2012  (9)
  3. 2013 To 2016  (284)
  4. 2017 To 2021  (12,061)
  5. After 2021  (754)
  6. More options open sub menu

Subject 

  1. Medical Research  (13,050)
  2. Corporate Profits  (10,515)
  3. Biotechnology Industry  (8,535)
  4. Earnings Per Share  (8,254)
  5. Business Metrics  (6,854)
  6. Stockholders  (4,797)
  7. Present Value  (3,952)
  8. Short Sales  (3,594)
  9. Capital Losses  (3,466)
  10. Capital Gains  (3,464)
  11. Equity  (3,348)
  12. Volatility  (2,676)
  13. Investments  (2,513)
  14. Stock Prices  (2,361)
  15. Dividends  (2,141)
  16. Current Liabilities  (2,140)
  17. Return On Assets  (2,006)
  18. Cash Flow  (1,965)
  19. More options open sub menu

Searching Remote Databases, Please Wait